GS Ang, JP Kersey, L Shepstone, DC … - British Medical Journal, 2008 - bjo.bmj.com Results: Data from 88 participants were analysed—54 were randomised to
treatment and 34 to the control group. The mean duration of treatment was 6
months. The average, maximum and minimum diurnal IOPs for treated patients ... Cited by 1 - Related articles - All 4 versions
N Yildirim, A Sahin, S Gultekin - Journal of Glaucoma, 2008 - journals.lww.com The Effect of Latanoprost, Bimatoprost, and Travoprost ... Nilgun Yildirim, MD,
Afsun Sahin, MD, and Saadet Gultekin, MD ... Purpose: To evaluate the efficacy
of latanoprost, bimatoprost, and travoprost given in the evening over the ... Cited by 5 - Related articles - BL Direct - All 2 versions
A Lafuma, G Berdeaux - Current Medical Research and Opinion®, 2007 - informahealthcare.com Objective: To compare the effectiveness and associated costs of travoprost
versus a fixed combination of dorzolamide + timolol as first-line therapy for
glaucoma according to data collected by the United Kingdom General ... Cited by 4 - Related articles - BL Direct - All 3 versions
I Kimura, K Shinoda, T Tanino, Y Ohtake, Y … - Japanese journal of ophthalmology, 2005 - Springer Unoprostone isopropyl is a chemically synthesized docosanoid (22-carbon basic
skeleton) that has been exten- sively evaluated by laboratory 1–3 and clinical
4–14 studies.The results of a clinical trial suggested that twice daily ... Cited by 4 - Related articles - All 4 versions
- ►iovs.org L Quaranta, S Miglior, I Floriani, T Pizzolante … - Investigative Ophthalmology & Visual Science, 2008 - ARVO METHODS. This was an institutional, randomized clinical trial. After a 24-hour
assessment without treatment, 27 previously untreated patients with POAG were
randomized to 6 weeks' treatment with twice-daily TDFC (8 AM and 8 PM) ... Cited by 4 - Related articles - All 4 versions
JB Jonas, WM Budde, A Stroux, IM Oberacher … - Eye, 2006 - nature.com In the whole study population, IOP amplitude was significantly (P<0.001) and
positively associated with the mean (r=0.26), minimal (r=-0.23) and maximal
(r=0.59) IOP values. Taking the whole study population, glaucoma ... Cited by 4 - Related articles - BL Direct - All 4 versions
JY Oh, KH Park - Korean Journal of Ophthalmology, 2005 - pdf.medrang.co.kr Despite many controversies about the origin and pathogenesis of NTG, many
reports have suggested that IOP reduction by filtering surgery 3-6 or medical
treatment 7,8 has favorable effects on visual field progression and optic ... Cited by 4 - Related articles - View as HTML - BL Direct - All 8 versions
W Trattler, RJ Noecker, ML Earl - Advances in Therapy, 2008 - Springer Introduction: The aim of this study was to evaluate the incidence of hyper-
aemia in patients using bimatoprost and to determine if simple interventions
result in increased understanding of glaucoma and hyperaemia. Methods: This ... Cited by 5 - Related articles - BL Direct - All 3 versions
ED Sharpe, CJ Henry, TK Mundorf, DG Day, JA … - Eye, 2004 - nature.com In this prospective, multi-centred, double-masked, crossover comparison,
patients were randomized to one treatment group for a 6-week treatment period,
and then crossed over to the opposite treatment. Measurements were ... Cited by 6 - Related articles - All 3 versions
A Sutton, A Gilvarry, A Ropo - Journal of Ocular Pharmacology and Therapeutics, 2007 - liebertonline.com ANDREW SUTTON, 1 ANNE GILVARRY, 2 and AULI ROPO 3 ... Objective: The aim of
this study was to determine the safety, tolerability, and pharmaco- dynamics of
a novel prostanoid fluoroprostaglandin (FP)-receptor agonist, tafluprost ... Cited by 6 - Related articles - BL Direct - All 3 versions
